{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:02:31Z","timestamp":1789599751789,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bbalip.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T20:01:44Z","timestamp":1503086504000},"page":"1562-1574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Distinct oxylipin alterations in diverse models of cystic kidney diseases"],"prefix":"10.1016","volume":"1862","author":[{"given":"Md","family":"Monirujjaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessay G.","family":"Devassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamio","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gabbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuko","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ravandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold M.","family":"Aukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2017.08.005_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0015","doi-asserted-by":"crossref","first-page":"212275","DOI":"10.7573\/dic.212275","article-title":"Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease","volume":"4","author":"Blanchette","year":"2015","journal-title":"Drugs Context"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrneph.2015.39","article-title":"Vasopressin and disruption of calcium signalling in polycystic kidney disease","volume":"11","author":"Chebib","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0030","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0035","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1097\/01.ASN.0000028643.17901.42","article-title":"Genetics and pathogenesis of polycystic kidney disease","volume":"13","author":"Igarashi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2015.12.079","article-title":"Chronic Kidney Disease in Children (CKiD) study, kidney disease progression in autosomal recessive polycystic kidney disease","volume":"171","author":"Dell","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.0.CO;2-Q","article-title":"Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology","volume":"76","author":"Zerres","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0050","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1542\/peds.2013-3646","article-title":"Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects","volume":"134","author":"Hartung","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MPG.0000000000000422","article-title":"Liver disease in autosomal recessive polycystic kidney disease: clinical characteristics and management in relation to renal failure","volume":"59","author":"Luoto","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MOP.0000000000000194","article-title":"Nephronophthisis and related syndromes","volume":"27","author":"Wolf","year":"2015","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0070","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Nephronophthisis","author":"Stokman","year":"2016"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0075","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1681\/ASN.2006121344","article-title":"Nephronophthisis-associated ciliopathies","volume":"18","author":"Hildebrandt","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00467-015-3162-y","article-title":"Nephronophthisis: should we target cysts or fibrosis?","volume":"31","author":"Slaats","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.2008050456","article-title":"Nephronophthisis: disease mechanisms of a ciliopathy","volume":"20","author":"Hildebrandt","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.plefa.2014.11.009","article-title":"Dietary flax oil rich in alpha-linolenic acid reduces renal disease and oxylipin abnormalities, including formation of docosahexaenoic acid derived oxylipins in the CD1-pcy\/pcy mouse model of nephronophthisis","volume":"94","author":"Yamaguchi","year":"2015","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11745-013-3859-2","article-title":"Renal cyclooxygenase products are higher and lipoxygenase products are lower in early disease in the pcy mouse model of adolescent nephronophthisis","volume":"49","author":"Yamaguchi","year":"2014","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0100","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/mnfr.201300332","article-title":"Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat","volume":"58","author":"Ibrahim","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0105","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","article-title":"Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology","volume":"50","author":"Buczynski","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0110","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.bbamem.2011.12.013","article-title":"Esterified eicosanoids: generation, characterization and function","volume":"1818","author":"Hammond","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2017.08.005_bb2005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0115","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0120","first-page":"5","article-title":"Eicosanoids: generation and detection in mammalian cells","volume":"462","author":"O'Donnell","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00041552-200001000-00005","article-title":"Prostaglandin receptors: their role in regulating renal function","volume":"9","author":"Breyer","year":"2000","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0135","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1152\/ajprenal.2000.279.1.F12","article-title":"Prostaglandin E receptors and the kidney","volume":"279","author":"Breyer","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0140","doi-asserted-by":"crossref","first-page":"F1622","DOI":"10.1152\/ajprenal.00036.2007","article-title":"EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells","volume":"293","author":"Elberg","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0145","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prostaglandins.2012.03.005","article-title":"Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells","volume":"98","author":"Elberg","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0155","first-page":"F659","article-title":"Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells","volume":"271","author":"Jensen","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","article-title":"Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease","volume":"30","author":"Yamaguchi","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0165","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2006111218","article-title":"Identification of a forskolin-like molecule in human renal cysts","volume":"18","author":"Putnam","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0175","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1681\/ASN.2015060634","article-title":"MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease","volume":"27","author":"Lakhia","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","article-title":"Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation","volume":"12","author":"Stork","year":"2002","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0185","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0190","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0b013e3283621510","article-title":"Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease","volume":"22","author":"Devuyst","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0200","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1194\/jlr.P042176","article-title":"Bioactive lipid mediators in polycystic kidney disease","volume":"55","author":"Klawitter","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0205","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.111","article-title":"A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5\u2032 end of Pkd1","volume":"73","author":"Starremans","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","article-title":"Somatic inactivation of Pkd2 results in polycystic kidney disease","volume":"93","author":"Wu","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0215","doi-asserted-by":"crossref","first-page":"e0155790","DOI":"10.1371\/journal.pone.0155790","article-title":"Lack of benefit of early intervention with dietary flax and fish oil and soy protein in orthologous rodent models of human hereditary polycystic kidney disease","volume":"11","author":"Yamaguchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1538\/expanim.49.51","article-title":"Characterization of a novel polycystic kidney rat model with accompanying polycystic liver","volume":"49","author":"Katsuyama","year":"2000","journal-title":"Exp. Anim."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1538\/expanim.61.477","article-title":"Animal models for human polycystic kidney disease","volume":"61","author":"Nagao","year":"2012","journal-title":"Exp. Anim."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11745-004-1221-7","article-title":"Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat","volume":"39","author":"Sankaran","year":"2004","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0235","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11745-015-4074-0","article-title":"Generation of bioactive oxylipins from exogenously added arachidonic, eicosapentaenoic and docosahexaenoic acid in primary human brain microvessel endothelial cells","volume":"51","author":"Aukema","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0240","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3945\/jn.113.177360","article-title":"Dietary linoleic acid and \u03b1-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats","volume":"143","author":"Caligiuri","year":"2013","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0076-6879(07)32003-X","article-title":"Detection and quantitation of eicosanoids via high performance liquid chromatography-electrospray ionization-mass spectrometry","volume":"432","author":"Deems","year":"2007","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1044-0305(98)00013-0","article-title":"Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids","volume":"9","author":"Hall","year":"1998","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0255","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00003226-200005001-00004","article-title":"8(S)-hydroxyeicosatetraenoic acid is the lipoxygenase metabolite of arachidonic acid that regulates epithelial cell migration in the rat cornea","author":"Yamada","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0260","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1084\/jem.150.2.406","article-title":"Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils","volume":"150","author":"Goetzl","year":"1979","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0265","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0006-291X(89)92682-X","article-title":"Oxidative metabolism of linoleic acid by human leukocytes","volume":"161","author":"Reinaud","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0270","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1164\/ajrccm.161.6.9906058","article-title":"Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact human lung vasculature","volume":"161","author":"Kiss","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0275","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2275(20)37802-0","article-title":"Autooxidation of docosahexaenoic acid: analysis of ten isomers of hydroxydocosahexaenoate","volume":"25","author":"VanRollins","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0280","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.freeradbiomed.2006.09.001","article-title":"Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease","volume":"41","author":"Shishehbor","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0026-895X(25)09920-1","article-title":"Overexpression of human prostaglandin G\/H synthease-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid","volume":"45","author":"O\u2019Neill","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0290","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.prostaglandins.2014.10.005","article-title":"Cyclooxygenase product inhibition with acetylsalicylic acid slows disease progression in the Han:SPRD-Cy rat model of polycystic kidney disease","volume":"116-117","author":"Ibrahim","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0295","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3181\/0811-RM-315","article-title":"Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease","volume":"234","author":"Peng","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0300","doi-asserted-by":"crossref","first-page":"F897","DOI":"10.1152\/ajprenal.00332.2005","article-title":"Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys","volume":"290","author":"Warford-Woolgar","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/MNH.0b013e32831a9df7","article-title":"Emerging roles for eicosanoids in renal diseases","volume":"18","author":"Camara","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0310","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4684-5700-1_11","article-title":"Eicosanoids: role in experimental renal disease","volume":"259","author":"Klahr","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0315","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0952-3278(89)90134-8","article-title":"Eicosanoids in renal function","volume":"36","author":"Lote","year":"1989","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0320","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0272-6386(95)90111-6","article-title":"Cyst fluid from a murine model of polycystic kidney disease stimulates fluid secretion, cyclic adenosine monophosphate accumulation, and cell proliferation by Madin-Darby canine kidney cells in vitro","volume":"25","author":"Yamaguchi","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0325","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00243.2011","article-title":"Tolvaptan inhibits ERK-dependent cell proliferation, Cl- secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin","volume":"301","author":"Reif","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0330","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2013121312","article-title":"Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model","volume":"26","author":"Hopp","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0340","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1124\/jpet.114.213256","article-title":"Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury","volume":"349","author":"Aihara","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0345","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0350","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/toxins8120376","article-title":"Modified lipids and lipoproteins in chronic kidney disease: a new class of uremic toxins","volume":"8","author":"Florens","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0355","first-page":"R767","article-title":"Vitamin E ameliorates enhanced renal lipid peroxidation and accumulation of F2-isoprostanes in aging kidneys","volume":"274","author":"Reckelhoff","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/abio.1993.1091","article-title":"Quantitation of hydroperoxy-eicosatetraenoic acids and hydroxy-eicosatetraenoic acids as indicators of lipid peroxidation using gas chromatography-mass spectrometry","volume":"209","author":"Guido","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0365","doi-asserted-by":"crossref","first-page":"R997","DOI":"10.1152\/ajpregu.00051.2007","article-title":"Female ROMK null mice manifest more severe Bartter II phenotype on renal function and higher PGE2 production","volume":"295","author":"Yan","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0370","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.HYP.0000156879.83448.93","article-title":"Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats","volume":"45","author":"Sullivan","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0375","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1081\/CEH-100102663","article-title":"The role of gender in salt-induced hypertension","volume":"23","author":"Bayorh","year":"2001","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0380","first-page":"30452","article-title":"Sex-biased eicosanoid biology: impact for sex differences in inflammation and consequences for pharmacotherapy","volume":"S0006-2952","author":"Pace","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0385","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1038\/s41598-017-03696-8","article-title":"Sex differences in prostaglandin biosynthesis in neutrophils during acute inflammation","volume":"7","author":"Pace","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jlb.40.2.133","article-title":"Gender-related variations and interaction of human neutrophil cyclooxygenase and oxidative burst metabolites","volume":"40","author":"Mallery","year":"1986","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0395","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0952-3278(90)90101-P","article-title":"Sex related differences in platelet TxA2 generation","volume":"40","author":"Pinto","year":"1990","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0400","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.plefa.2017.01.004","article-title":"Identification and profiling of specialized pro-resolving mediators in human tears by lipid mediator metabolomics","volume":"117","author":"English","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0405","doi-asserted-by":"crossref","first-page":"1914S","DOI":"10.3945\/ajcn.110.000893","article-title":"Sex-specific differences in essential fatty acid metabolism","volume":"94","author":"Decsi","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0410","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.atherosclerosis.2015.02.033","article-title":"Association of serum eicosapentaenoic acid to arachidonic acid ratio with microalbuminuria in a population of community-dwelling Japanese","volume":"239","author":"Fukami","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0415","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/CIRCULATIONAHA.114.011590","article-title":"Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study","volume":"130","author":"Wu","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0420","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.1103333","article-title":"COX-2-derived prostacyclin confers atheroprotection on female mice","volume":"306","author":"Egan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2017.08.005_bb0425","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0024-3205(87)90257-8","article-title":"Effects of gonadectomy and steroid treatment on renal prostaglandin 9-ketoreductase activity in the rat","volume":"40","author":"Cagen","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0430","doi-asserted-by":"crossref","first-page":"F342","DOI":"10.1152\/ajprenal.00366.2011","article-title":"Sex hormones induce a gender-related difference in renal expression of a novel prostaglandin transporter, OAT-PG, influencing basal PGE2 concentration","volume":"302","author":"Hatano","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0435","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5527\/wjn.v4.i4.468","article-title":"Current management of autosomal dominant polycystic kidney disease","volume":"4","author":"Akoh","year":"2015","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0440","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ki.2014.120","article-title":"Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease","volume":"86","author":"Spithoven","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0445","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14656566.2014.903923","article-title":"Pharmacological management of polycystic kidney disease","volume":"15","author":"Wuthrich","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0450","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1046\/j.1523-1755.2000.00093.x","article-title":"A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats","volume":"57","author":"Wang","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0455","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1007\/s11033-012-1611-2","article-title":"Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF\/Raf\/MAPK\/ERK signaling pathway","volume":"39","author":"Xu","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbalip.2017.08.005_bb0460","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1523-1755.2002.00520.x","article-title":"Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension","volume":"62","author":"Cheng","year":"2002","journal-title":"Kidney Int."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819811730152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819811730152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:32:29Z","timestamp":1750807949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138819811730152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S138819811730152X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2017.08.005","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct oxylipin alterations in diverse models of cystic kidney diseases","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}